BCG vaccination and tuberculosis in Japan

Mahbubur Rahman, Osamu Takahashi, Masashi Goto, Tsuguya Fukui

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This paper summarizes Bacillus Calmette-Guérin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports. Universal BCG vaccination in infants and revaccination among children were not found economically justifiable. Overall tuberculosis incidence in Japan is higher than that of other developed countries. Trend of decline in tuberculosis incidence is similar to that of the countries where universal BCG vaccination has never been implemented. In the recent years, the number of tuberculosis group infection has been escalating. Since BCG revaccination program has already been discontinued, a consensus on universal BCG vaccination is also essential based on social, political, and economical factors. Side by side, more pragmatic strategies such as well-defined tuberculin test, selective vaccination policy based on tuberculosis incidence in each administrative zone, and early vaccination of high risk groups, should be formulated.

Original languageEnglish (US)
Pages (from-to)127-135
Number of pages9
JournalJournal of Epidemiology
Volume13
Issue number3
StatePublished - 2003
Externally publishedYes

Fingerprint

Bacillus
Japan
Vaccination
Tuberculosis
Secondary Immunization
Incidence
Tuberculin Test
Politics
Developed Countries
Cost-Benefit Analysis
Databases
Infection

Keywords

  • BCG
  • Cost-effectiveness
  • Japan
  • Tuberculosis

ASJC Scopus subject areas

  • Epidemiology

Cite this

Rahman, M., Takahashi, O., Goto, M., & Fukui, T. (2003). BCG vaccination and tuberculosis in Japan. Journal of Epidemiology, 13(3), 127-135.

BCG vaccination and tuberculosis in Japan. / Rahman, Mahbubur; Takahashi, Osamu; Goto, Masashi; Fukui, Tsuguya.

In: Journal of Epidemiology, Vol. 13, No. 3, 2003, p. 127-135.

Research output: Contribution to journalArticle

Rahman, M, Takahashi, O, Goto, M & Fukui, T 2003, 'BCG vaccination and tuberculosis in Japan', Journal of Epidemiology, vol. 13, no. 3, pp. 127-135.
Rahman M, Takahashi O, Goto M, Fukui T. BCG vaccination and tuberculosis in Japan. Journal of Epidemiology. 2003;13(3):127-135.
Rahman, Mahbubur ; Takahashi, Osamu ; Goto, Masashi ; Fukui, Tsuguya. / BCG vaccination and tuberculosis in Japan. In: Journal of Epidemiology. 2003 ; Vol. 13, No. 3. pp. 127-135.
@article{32260308f0f443e2a29c71a7fa78e275,
title = "BCG vaccination and tuberculosis in Japan",
abstract = "This paper summarizes Bacillus Calmette-Gu{\'e}rin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports. Universal BCG vaccination in infants and revaccination among children were not found economically justifiable. Overall tuberculosis incidence in Japan is higher than that of other developed countries. Trend of decline in tuberculosis incidence is similar to that of the countries where universal BCG vaccination has never been implemented. In the recent years, the number of tuberculosis group infection has been escalating. Since BCG revaccination program has already been discontinued, a consensus on universal BCG vaccination is also essential based on social, political, and economical factors. Side by side, more pragmatic strategies such as well-defined tuberculin test, selective vaccination policy based on tuberculosis incidence in each administrative zone, and early vaccination of high risk groups, should be formulated.",
keywords = "BCG, Cost-effectiveness, Japan, Tuberculosis",
author = "Mahbubur Rahman and Osamu Takahashi and Masashi Goto and Tsuguya Fukui",
year = "2003",
language = "English (US)",
volume = "13",
pages = "127--135",
journal = "Journal of Epidemiology",
issn = "0917-5040",
publisher = "Japan Epidemiology Association",
number = "3",

}

TY - JOUR

T1 - BCG vaccination and tuberculosis in Japan

AU - Rahman, Mahbubur

AU - Takahashi, Osamu

AU - Goto, Masashi

AU - Fukui, Tsuguya

PY - 2003

Y1 - 2003

N2 - This paper summarizes Bacillus Calmette-Guérin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports. Universal BCG vaccination in infants and revaccination among children were not found economically justifiable. Overall tuberculosis incidence in Japan is higher than that of other developed countries. Trend of decline in tuberculosis incidence is similar to that of the countries where universal BCG vaccination has never been implemented. In the recent years, the number of tuberculosis group infection has been escalating. Since BCG revaccination program has already been discontinued, a consensus on universal BCG vaccination is also essential based on social, political, and economical factors. Side by side, more pragmatic strategies such as well-defined tuberculin test, selective vaccination policy based on tuberculosis incidence in each administrative zone, and early vaccination of high risk groups, should be formulated.

AB - This paper summarizes Bacillus Calmette-Guérin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports. Universal BCG vaccination in infants and revaccination among children were not found economically justifiable. Overall tuberculosis incidence in Japan is higher than that of other developed countries. Trend of decline in tuberculosis incidence is similar to that of the countries where universal BCG vaccination has never been implemented. In the recent years, the number of tuberculosis group infection has been escalating. Since BCG revaccination program has already been discontinued, a consensus on universal BCG vaccination is also essential based on social, political, and economical factors. Side by side, more pragmatic strategies such as well-defined tuberculin test, selective vaccination policy based on tuberculosis incidence in each administrative zone, and early vaccination of high risk groups, should be formulated.

KW - BCG

KW - Cost-effectiveness

KW - Japan

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0038348808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038348808&partnerID=8YFLogxK

M3 - Article

C2 - 12749599

AN - SCOPUS:0038348808

VL - 13

SP - 127

EP - 135

JO - Journal of Epidemiology

JF - Journal of Epidemiology

SN - 0917-5040

IS - 3

ER -